Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Documento de consenso del Grupo Español de Psoriasis (GPS) y del grupo Español de Dermatología Pediátrica (GEDP) de la Academia Española de Dermatología y Venereología (AEDV) sobre el manejo de la psoriasis pediátrica.
Vicente A, Pérez-Ferriols A, Batalla A, García-Fernandez L, Pérez B, Eiris N, de Lucas R, De La Cueva P, Carrascosa JM. Vicente A, et al. Among authors: de la cueva p. Actas Dermosifiliogr. 2024 Dec 23:S0001-7310(24)01004-4. doi: 10.1016/j.ad.2024.12.015. Online ahead of print. Actas Dermosifiliogr. 2024. PMID: 39722345 English, Spanish.
Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study.
Martorell-Calatayud A, Santos-Alarcón S, Sahuquillo-Torralba A, Rivera-Díaz R, Belinchón-Romero I, Ruiz-Genao D, Romero-Maté A, Ruiz-Villaverde R, Ferran-Farrés M, Gallardo-Hernández F, Almenara-Blasco M, Suarez-Perez JA, González-Cantero Á, Martínez-Lorenzo E, Fernández-Armenteros JM, Del Alcázar-Viladomiu E, García-Latasa J, Rocamora-Durant V, Ara-Martín M, Mateu-Puchades A, Llamas-Velasco M, Vilarrasa E, Velasco-Pastor M, De la Cueva P, Carrascosa JM, Magdaleno-Tapial J. Martorell-Calatayud A, et al. Among authors: de la cueva p. Actas Dermosifiliogr. 2024 Oct 23:S0001-7310(24)00854-8. doi: 10.1016/j.ad.2024.10.042. Online ahead of print. Actas Dermosifiliogr. 2024. PMID: 39454868 English, Spanish.
Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice.
Butrón-Bris B, Llamas-Velasco M, Ovejero-Benito MC, Santos-Juanes J, Martínez-López A, Ruiz-Villaverde R, Roustan G, Baniandrés O, Izu-Belloso R, de la Cueva P, Sahuquillo-Torralba A, Gónzalez-Quesada A, Vilarrasa-Rull E, Pujol-Montcusí J, García-Martínez J, Navares M, Palomar-Moreno I, Novalbos J, Abad-Santos F, Daudén E, de la Fuente H. Butrón-Bris B, et al. Among authors: de la cueva p. Exp Dermatol. 2024 Aug;33(8):e15152. doi: 10.1111/exd.15152. Exp Dermatol. 2024. PMID: 39081053 Free PMC article.
Consensus Statement from the Spanish Academy of Dermatology and Venereology (AEDV) Psoriasis Working Group (SWG) and Pediatric Working Group (PWG) on the Management of Pediatric Psoriasis.
Vicente A, Pérez-Ferriols A, Batalla A, García-Fernandez L, Pérez B, Eiris N, de Lucas R, De La Cueva P, Carrascosa JM. Vicente A, et al. Among authors: de la cueva p. Actas Dermosifiliogr. 2024 Jul 18:S0001-7310(24)00597-0. doi: 10.1016/j.ad.2024.06.007. Online ahead of print. Actas Dermosifiliogr. 2024. PMID: 39032783 English, Spanish.
[Translated article] Recommendations from the Spanish Academy of Dermatology and Venereology Psoriasis Working Group on the Management of Patients with Cancer and Psoriasis.
Puig L, Notario J, López-Ferrer A, Scheneller-Pavelescu L, Pérez B, Galache C, de la Cueva P, Carrascosa JM. Puig L, et al. Among authors: de la cueva p. Actas Dermosifiliogr. 2024 Jul-Aug;115(7):T702-T711. doi: 10.1016/j.ad.2024.05.011. Epub 2024 May 29. Actas Dermosifiliogr. 2024. PMID: 38821353 Free article. English, Spanish.
Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study.
Martorell A, Santos-Alarcón S, Sahuquillo-Torralba A, Rivera-Díaz R, Belinchón-Romero I, Ruiz-Genao D, Romero-Maté A, Ruiz-Villaverde R, Ferran-Farrés M, Gallardo-Hernández F, Almenara-Blasco M, Suarez-Perez JA, González-Cantero Á, Martínez-Lorenzo E, Fernández-Armenteros JM, Del Alcázar-Viladomiu E, García-Latasa J, Rocamora-Durant V, Ara-Martín M, Mateu-Puchades A, Llamas-Velasco M, Vilarrasa E, Velasco-Pastor M, De la Cueva P, Carrascosa JM, Magdaleno-Tapial J. Martorell A, et al. Among authors: de la cueva p. Actas Dermosifiliogr. 2024 Mar 6:S0001-7310(24)00187-X. doi: 10.1016/j.ad.2024.02.030. Online ahead of print. Actas Dermosifiliogr. 2024. PMID: 38452889 English, Spanish.
Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting.
Daudén E, Escario E, Martos-Cabrera L, Armesto S, Herrera-Acosta E, Vidal D, Vilarrasa E, Rivera R, de la Cueva P, Martorell A, Ballesca F, Belinchón I, Carretero G, Rodríguez L, Romero-Maté A, Pujol-Montcusí J, Salgado L, Sahuquillo-Torralba A, Coto-Segura P, Baniandrés O, Feltes R, Riera-Monroig J, Garrido J, Llamas-Velasco M. Daudén E, et al. Among authors: de la cueva p. Int J Dermatol. 2024 Apr;63(4):503-511. doi: 10.1111/ijd.16915. Epub 2024 Jan 2. Int J Dermatol. 2024. PMID: 38168847
Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practice.
Muñoz-Aceituno E, Butrón-Bris B, Ovejero-Benito MC, Sahuquillo-Torralba A, Baniandrés Rodríguez O, Herrera-Acosta E, Rivera-Diaz R, Ferran M, Sánchez-Carazo JL, Riera-Monroig J, Pujol-Montcusí J, Vidal D, de la Cueva P, García-Bustinduy M, Ruiz-Villaverde R, Ballescà F, Llamas-Velasco M, Navares M, Palomar-Moreno I, Sánchez-García I, García-Martínez J, Novalbos J, Zubiaur P, Abad-Santos F, Daudén-Tello E, de la Fuente H. Muñoz-Aceituno E, et al. Among authors: de la cueva p. J Eur Acad Dermatol Venereol. 2024 Sep;38(9):1783-1790. doi: 10.1111/jdv.19782. Epub 2023 Dec 28. J Eur Acad Dermatol Venereol. 2024. PMID: 38153843
Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish Dermatologists.
Vilarrasa E, Rivera R, Eiris N, Carretero G, de la Cueva P, Carrascosa JM. Vilarrasa E, et al. Among authors: de la cueva p. Actas Dermosifiliogr. 2024 May;115(5):449-457. doi: 10.1016/j.ad.2023.10.022. Epub 2023 Nov 2. Actas Dermosifiliogr. 2024. PMID: 37925068 Free article. English, Spanish.
149 results